Pharmacology, Toxicology and Pharmaceutical Science

1. Rheumatoid Arthritis 100%
2. Inflammatory Arthritis 100%
3. Cohort Study 71%
4. Monoclonal Antibody 39%
5. Diseases 33%
6. Randomized Controlled Trial 31%
7. Gout 29%
8. Adverse Event 29%
9. Methotrexate 26%
10. Disease Modifying Antirheumatic Drug 24%
11. Remission 19%
12. Janus Kinase Inhibitor 18%
13. Abatacept 17%
14. Ecological Study 16%
15. Observational Study 15%
16. Sarcoidosis 14%
17. Prevalence 14%
18. Leflunomide 14%
19. Uveitis 14%
20. Pneumococcus Vaccine 14%
21. Antiviral Drug 14%
22. Pneumocystis Pneumonia 14%
23. Urate 14%
24. Coronavirinae 14%
25. Azathioprine 14%
26. Iridocyclitis 14%
27. Spondylarthritis 14%
28. Antirheumatic Agent 14%
29. Immunogenicity 14%
30. Necrosis 13%
31. Monotherapy 12%
32. Placebo 11%
33. Molnupiravir 11%
34. Pandemic 11%
35. Tumor Necrosis Factor Inhibitor 8%
36. Rituximab 8%
37. Etanercept 7%
38. Randomized Clinical Trial 7%
39. Infection 6%
40. Colchicine 6%
41. Streptococcus pneumonia 5%
42. Standardized Mortality Ratio 5%
43. All Cause Mortality 5%
44. Pharmacovigilance 5%